Stanford University School of Medicine researchers have found that genetically altered tobacco plants can produce an anti-cancer vaccine that can stop the spread of follicular B-cell lymphoma, an immune system malignancy.
That type of cancer is diagnosed in about 16,000 people a year and is considered a chronic, incurable disease.

CHICAGO (AFP) - Researchers have developed a plant-based cancer vaccine capable of kick-starting the body's immune response and being tailored to a patient's specific tumor type, according to a study released Monday.
While they have not yet determined whether the immune response is sufficient to destroy the cancer, the researchers are hopeful that the technique could one day lead to a cure for at lease some types of the deadly disease.
et the immune system revved up, it can attack and kill cancer."

STANFORD, Calif., Jul 21, 2008 (BUSINESS WIRE) - Plants could act as safe, speedy factories for growing antibodies for personalized treatments against a common form of cancer, according to new findings from the Stanford University School of Medicine. The findings came in the first human tests of an injectable vaccine grown in genetically engineered plants.
The treatments, which would vaccinate cancer patients against their malignant cells, could lead to earlier personalized therapy to tackle follicular B-cell lymphoma, an immune-system malignancy diagnosed in about 16,000 people each year.
akes months, costs thousands of dollars per patient and comes with the theoretical